Sign in

NCT06775067Completed

Incremental Dialysis Decision Model Based on Expert-Guided Machine Learning

Machine Learning Based on Expert Knowledge to Build and Validate a Decision Model for Incremental Dialysis

Source: ClinicalTrials.gov · Last updated 14 Jan 2025

Brief summary (registry, in English)

This observational prospective study combined clinical expert knowledge with machine learning to develop and validate a predictive model for incremental hemodialysis decision-making. The aim of the predictive model is to assist clinicians in developing individualized incremental dialysis treatment plans to optimize patient outcomes.

Status (registry)
Completed
Study type
Observational
Enrollment
175 (actual)
First submitted
5 Jan 2025
Start date
12 Apr 2010
Primary completion date
28 Jun 2024
Lead sponsor
Huashan Hospital
NCT number
NCT06775067

What you commit to

  • Study type: Observational
  • Participants enrolled: 175
  • From 12 Apr 2010 to the primary completion date, 28 Jun 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Liver disease, heart failure, or severe comorbidities.

Other

  • Incomplete/unreliable data.
  • Twice-weekly palliative dialysis.
  • No baseline urine output or ≤200 mL/24h.

Who the study is looking for

  • New hemodialysis patients (Apr 2010-Jun 2024), started within 3 months, including transfers.
  • Age ≥18, stable hemodialysis \>6 months.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Huashan Hospital, Fudan University
Coordinator of this site? Confirm its status
ShanghaiChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.